Antihypertensive Use Tied to Higher Fall Risk Across Groups
A recent study found that initiating antihypertensive therapy in patients aged 40 and older is linked to a higher risk of hospitalization or death due to falls. This increased risk was observed across various demographic groups, including differences in sex, ethnicity, and socioeconomic status. The findings suggest that careful consideration is needed when prescribing antihypertensive medications to these patients.
- ▪The study analyzed data from over 2.5 million patients aged 40 years or older with systolic blood pressure readings of 130-179 mm Hg.
- ▪Hospitalization or death due to falls occurred in 4.2% of patients, with a higher rate of 7.1% in those who received antihypertensive treatment.
- ▪Elevated risks for hospitalization or death due to hypotension, syncope, and acute kidney injury were also noted among those treated with antihypertensives.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/antihypertensive-treatment-tied-increased-fall-risk-across-2026a1000h49?src=rss |
| Publication time | Wed, 27 May 2026 08:00:00 EDT |
| Retrieval time | 2026-05-27T12:07:59.258Z |
| Last seen | 2026-05-27T12:07:59.258Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 3R-TB_FQ3MqK |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
TOPLINE:In patients aged 40 years or older with a systolic blood pressure of 130-179 mm Hg, initiating antihypertensive therapy was associated with an increased risk for hospitalisation or death due to falls, hypotension, syncope, and acute kidney injury. Increased risks were noted across subgroups based on sex, ethnicity, and socioeconomic status.METHODOLOGY:Researchers conducted an observational cohort study using retrospective data from primary care from the Clinical Practice Research Datalink Aurum database in England from 1998 to 2018.They included data of more than 2.5 million patients aged 40 years or older who had not previously received antihypertensive treatment and had systolic blood pressure readings of 130-179 mm Hg.Exposure to treatment was defined as receiving a…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
